References
- Lang JA, Kim J. Remote ischaemic preconditioning – translating cardiovascular benefits to humans. J. Physiol. 2022 Jul;600(13):3053-67. doi: 10.1113/JP282568. Epub 2022 May 31. PMID: 35596644; PMCID: PMC9327506.
- Laurikka J, Wu Z-K, Iisalo P, Kaukinen L, Honkonen EL, Kaukinen S, Tarkka MR. Regional ischemic preconditioning enhances myocardial performance in off-pump coronary artery bypass grafting. Chest. Apr 2002;121(4):1183-89. doi: 10.1378/chest.121.4.1183
- Gunata M, Parlakpinar H. A review of myocardial ischaemia/reperfusion injury: Pathophysiology, experimental models, biomarkers, genetics and pharmacological treatment, Cell Biochem Funct. 2021 Mar;39(2):190-217. doi: 10.1002/cbf.3587.
- Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74(5):1124-36. doi: 10.1161/01.cir.74.5.1124.
- Liu GS, Stanley AW, Downey JM. Ischaemic preconditioning is not dependent on neutrophils or glycolytic substrate at reperfusion in rabbit heart. Cardiovasc. Res. 1992;26(12):1195-98. doi: 10.1093/cvr/26.12.1195.
- Vahlhaus C, Schulz R, Post H, Rose J, Heusch G. Prevention of ischemic preconditioning only by combined inhibition of protein kinase C and protein tyrosine kinase in pigs. J. Mol. Cell. Cardiol. 1998 Feb;30(2):197-209. doi: 10.1006/jmcc.1997.0609.
- Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P. Regional ischemic “preconditioning” protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation. 1993 Mar;87(3):893-9. doi: 10. 1159/000108686.
- Heusch G. (2018). 25 years of remote ischemic conditioning: from laboratory curiosity to clinical outcome. Basic Res. Cardiol. 2018 Mar 7;113(3):15. doi: 10.1007/s00395-018-0673-2.
- Heusch, G, Botker HE, Przyklenk K, Redington A, Yellon D. (2015). Remote ischemic conditioning. J. Am. Coll. Cardiol. 2015 Jan 20;65(2):177-95. doi: 10.1016/j.jacc.2014.10.031.
- Bielli A, Scioli MG, Mazzaglia D, Doldo E, Orlandi A. Antioxidants and vascular health. Life Sci. 2015 Dec 15:143:209-16. doi: 10.1016/j. lfs.2015.11.012
- Poznyak AV, Grechko AV, Orekhova VA, Chegodaev YS, Wu WK, Orekhov AN. Oxidative stress and antioxidants in atherosclerosis development and treatment. Biology (Basel). 2020 Mar 21;9(3):60. doi: 10.3390/biology9030060.
- Wassmann S, Wassmann K, Nickenig G. Modulation of oxidant and antioxidant enzyme expression and function in vascular cells. Hypertension. 2004 Oct;44(4):381-6. doi: 10.1161/01.HYP.0000142232.29764.a7.
- Hausenloy DJ, Yellon DM. The therapeutic potential of ischemic conditioning: an update. Nat Rev Cardiol. 2016;13(11):679-89.
- Benstoem C, Stoppe C, Liakopoulos OJ, Ney J, Hasenclever D, Meybohm P, Goetzenich A. Remote ischaemic preconditioning for coronary artery bypass grafting (with or without valve surgery). Cochrane Database of Syst. Rev. 2017 May 5;5(5): CD011719. doi: 10.1002/14651858.CD011719.pub3.
- Turner NA, Das A, Warburton P. (2014). IL-1 in myocardial infarction and heart failure: It’s all about context. J. Mol. Cell. Cardiol. 2014 Apr;69(75):83-93. doi: 10.1016/j.yjmcc.2014.01.014
- Hausenloy DJ, Yellon DM (2015). Ischaemic conditioning and reperfusion injury. Nat Rev Cardiol. 2016 Apr;13(4):193-209. doi: 10.1038/nrcardio.2015.25
- Heusch G. (2015). Molecular basis of cardioprotection: Signal transduction in ischemic pre-, post-, and remote conditioning. Circ. Res. 2015 Feb 13;116(4):674-99. doi: 10.1161/CIRCRESAHA.116.305348
- Vilahur G, Gutiérrez M, Casani L, Cubedo J, Badimon L. (2014). Role of IL-1 in the modulation of vascular and myocardial injury: Effects of IL-1 inhibition. J. Am. Coll. Cardiol. 20 May 2014;63(21):2395-408. doi: 10.1016/j.jacc.2014.02.548
- Zhou W, Zeng D, Chen R, Zhang Y. (2016). Role of IL-6 in cardioprotection of remote ischemic preconditioning. J. Am. Coll. Cardiol. 67(13), 1504-1505.
- Biasucci LM, Graziani F, Rizzello V, Liuzzo G. (2019). Inflammatory cytokines in ischemic heart disease: Focus on IL-6 as therapeutic target. Current Pharmaceutical Design, 25(2), 247-253.
- Heusch G, Musiolik J, Gedik N, Skyschally A. (2015). Cardioprotection by ischemic conditioning and its signal transduction. Circulation Research, 116(4), 674-699.
- Ridker PM, Macfadyen JG., Thuren T, Everett BM, Libby P, Glynn RJ. (2020). Effect of interleukin-6 inhibition with ziltivekimab on cardiovascular outcomes in patients with chronic kidney disease and high atherosclerotic risk: Rationale and design of the RESCUE trial. American Heart Journal, 235, 1-9.
- Liao Z, Wang W, Shen H. (2020). Systemic inflammatory response syndrome after cardiac surgery: Role of IL-6 and therapeutic implications. Journal of Cardiothoracic Surgery, 15(1), 1-9.
- Shimizu M, Tropak M, Diaz RJ, Suto F, Surendra H, Kuzmin E, Li J, Wilson GJ, Callahan J, Redington AN. Transient limb ischemia remotely preconditions through a humoral mechanism acting directly on cardiomyocytes: evidence suggesting cross-species protection. 2009 Aug 3;117(5):191-200. doi: 10.1042/CS20080523.
- Fiorentino, F, Angelini, GD, Suleiman, MS, Rahman A, Anderson J, Bryan AJ, Culliford LA, Moscarelli M, Punjabi PP, Reeves BC. Investigating the effect of remote ischaemic preconditioning on biomarkers of stress and injury-related signalling in patients having isolated coronary artery bypass grafting or aortic valve replacement using cardiopulmonary bypass: study protocol for a randomized controlled trial. Trials. 2015;16(181). doi: 10.1186/s13063-015-0696-z
- Chen J, Su T, Li S. (2011). LOX-1 and ROS signaling: linking atherosclerosis and RIPC. Journal of Molecular and Cellular Cardiology, 51(2), 198-203.
- Bifari AE, Sulaimani RK, Khojah YS, Almaghrabi OS, Alshaikh HA, Al-Ebrahim KE. Cardiovascular risk factors in coronary artery bypass graft patients: comparison between two periods. Cureus. 2020 Sep 21;12(9):e10561. doi: 10.7759/cureus.10561. PMID: 33101808; PMCID: PMC7577304.
- Mehta LS, Beckie TM, Devon HA, Grines CL, Krumholz HM, Johnson MN, Lindley KJ, Vaccarino V, Wang TY, Watson KE, Wenger NK. American Heart Association Cardiovascular Disease in Women and Special Populations Committee of the Council on Clinical Cardiology, Council on Epidemiology and Prevention, Council on Cardiovascular and Stroke Nursing, and Council on Quality of Care and Outcomes Research. Acute myocardial infarction in women: A scientific statement from the American Heart Association. Circulation. 2016 Mar 1;133(9):916-47. doi: 10.1161/CIR.0000000000000351. Epub 2016 Jan 25. PMID: 26811316.
- Damaskos C, Garmpis N, Kollia P, Mitsiopoulos G, Barlampa D, Drosos A, Patsouras A, Gravvanis N, Antoniou V, Litos A, Diamantis E. Assessing cardiovascular risk in patients with diabetes: an update. Curr. Cardiol. Rev. 2020;16(4):266-274. doi: 10.2174/1573403X15666191111123622. PMID: 31713488; PMCID: PMC7903509.
- Eagle KA, Rihal CS, Foster ED, Mickel MC, Gersh BJ. Long-term survival in patients with coronary artery disease: importance of peripheral vascular disease. The Coronary Artery Surgery Study (CASS) Investigators. J. Am. Coll. Cardiol. 1994 Apr;23(5):1091-5. doi: 10.1016/0735-1097(94)90596-7. PMID: 8144774.
- Hausenloy DJ, Yellon DM. Ischaemic conditioning and reperfusion injury. Nat. Rev. Cardiol. 2016 Apr;13(4):193-209. doi: 10.1038/nrcardio.2016.5. Epub 2016 Feb 4. PMID: 26843289.